Search Results - "McKendrick, J"

Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy by Twelves, C., Scheithauer, W., McKendrick, J., Seitz, J.-F., Van Hazel, G., Wong, A., Díaz-Rubio, E., Gilberg, F., Cassidy, J.

“…This multicenter randomized trial compared oral capecitabine with bolus i.v. 5-fluorouracil (5-FU)/folinic acid (FA) as adjuvant therapy for stage III colon…”
Get full text

Self-Assembly of Peptide Nanotubes in an Organic Solvent by Krysmann, M. J, Castelletto, V, McKendrick, J. E, Clifton, L. A, Harris, P. J. F, King, S. M

“…The self-assembly of a modified fragment of the amyloid β peptide, based on sequence Aβ(16−20), KLVFF, extended to give AAKLVFF is studied in methanol…”
Get full text

FAIR data pipeline: provenance-driven data management for traceable scientific workflows by Mitchell, Sonia Natalie, Lahiff, Andrew, Cummings, Nathan, Hollocombe, Jonathan, Boskamp, Bram, Field, Ryan, Reddyhoff, Dennis, Zarebski, Kristian, Wilson, Antony, Viola, Bruno, Burke, Martin, Archibald, Blair, Bessell, Paul, Blackwell, Richard, Boden, Lisa A, Brett, Alys, Brett, Sam, Dundas, Ruth, Enright, Jessica, Gonzalez-Beltran, Alejandra N, Harris, Claire, Hinder, Ian, David Hughes, Christopher, Knight, Martin, Mano, Vino, McMonagle, Ciaran, Mellor, Dominic, Mohr, Sibylle, Marion, Glenn, Matthews, Louise, McKendrick, Iain J, Mark Pooley, Christopher, Porphyre, Thibaud, Reeves, Aaron, Townsend, Edward, Turner, Robert, Walton, Jeremy, Reeve, Richard

“…Modern epidemiological analyses to understand and combat the spread of disease depend critically on access to, and use of, data. Rapidly evolving data, such as…”
Get full text

PEGylated Amyloid Peptide Nanocontainer Delivery and Release System by Castelletto, V, McKendrick, J. E, Hamley, I. W, Olsson, U, Cenker, C

“…A micellar nanocontainer delivery and release system is designed on the basis of a peptide−polymer conjugate. The hybrid molecules self-assemble into micelles…”
Get full text

Lymphoid Follicle-Dense Mucosa at the Terminal Rectum Is the Principal Site of Colonization of Enterohemorrhagic Escherichia coli O157:H7 in the Bovine Host by NAYLOR, Stuart W, LOW, J. Christopher, BESSER, Thomas E, MAHAJAN, Arvind, GUNN, George J, PEARCE, Michael C, MCKENDRICK, Iain J, SMITH, David G. E, GALLY, David L

“…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group by André, T., Vernerey, D., Im, S.A., Bodoky, G., Buzzoni, R., Reingold, S., Rivera, F., McKendrick, J., Scheithauer, W., Ravit, G., Fountzilas, G., Yong, W.P., Isaacs, R., Österlund, P., Liang, J.T., Creemers, G.J., Rakez, M., Van Cutsem, E., Cunningham, D., Tabernero, J., de Gramont, A.

“…The bevacizumab-Avastin® adjuVANT (AVANT) study did not meet its primary end point of improving disease-free survival (DFS) with the addition of bevacizumab to…”
Get full text

A novel antibacterial peptide derived from Crocodylus siamensis haemoglobin hydrolysate induces membrane permeabilization causing iron dysregulation, oxidative stress and bacterial death by Lueangsakulthai, J., Jangpromma, N., Temsiripong, T., McKendrick, J.E., Khunkitti, W., Maddocks, S.E., Klaynongsruang, S.

“…Aims A novel antibacterial peptide from Crocodylus siamensis haemoglobin hydrolysate (CHH) was characterized for antimicrobial activity. Methods and Results…”
Get full text

The challenges of data in future pandemics by Shadbolt, Nigel, Brett, Alys, Chen, Min, Marion, Glenn, McKendrick, Iain J., Panovska-Griffiths, Jasmina, Pellis, Lorenzo, Reeve, Richard, Swallow, Ben

“…The use of data has been essential throughout the unfolding COVID-19 pandemic. We have needed it to populate our models, inform our understanding, and shape…”
Get full text

Successful immunization against a parasitic nematode by vaccination with recombinant proteins by Nisbet, Alasdair J, McNeilly, Tom N, Wildblood, Louise A, Morrison, Alison A, Bartley, David J, Bartley, Yvonne, Longhi, Cassandra, McKendrick, Iain J, Palarea-Albaladejo, Javier, Matthews, Jacqueline B

“…Highlights • A recombinant sub-unit vaccine protected sheep against Teladorsagia circumcincta. • Vaccine consists of a cocktail of immunomodulatory and…”
Get full text

Scenario planning as communicative action: Lessons from participatory exercises conducted for the Scottish livestock industry by Duckett, Dominic George, McKee, Annie J., Sutherland, Lee-Ann, Kyle, Carol, Boden, Lisa A., Auty, Harriet, Bessell, Paul R., McKendrick, Iain J.

“…Based on Habermas' Theory of Communicative Action, this paper critiques the transparency and legitimacy of participatory scenario planning, considering a case…”
Get full text

Super-shedding cattle and the transmission dynamics of Escherichia coli O157 by MATTHEWS, L., McKENDRICK, I. J., TERNENT, H., GUNN, G. J., SYNGE, B., WOOLHOUSE, M. E. J.

“…The prevalence of Escherichia coli O157 displays striking variability across the Scottish cattle population. On 78% of farms, in a cross-sectional survey of…”
Get full text

Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial by Scheithauer, W., McKendrick, J., Begbie, S., Borner, M., Burns, W. I., Burris, H. A., Cassidy, J., Jodrell, D., Koralewski, P., Levine, E. L., Marschner, N., Maroun, J., Garcia-Alfonso, P., Tujakowski, J., Van Hazel, G., Wong, A., Zaluski, J., Twelves, C.

“…Background: Oral capecitabine achieves a superior response rate with an improved safety profile compared with bolus 5-fluorouracil–leucovorin (5-FU/LV) as…”
Get full text

Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer : the X-ACT trial by CASSIDY, J, DOUILLARD, J.-Y, COXON, F, DIAZ-RUBIO, E, MAUGHAN, T. S, MALZYNER, A, BERTETTO, O, BEHAM, A, FIGER, A, DUFOUR, P, PATEL, K. K, COWELL, W, TWELVES, C, GARRISON, L. P, MCKENDRICK, J. J, SCHEITHAUER, W, BUSTOVA, I, JOHNSTON, P. G, LESNIEWSKI-KMAK, K, JELIC, S, FOUNTZILAS, G

“…Oral capecitabine (Xeloda) is an effective drug with favourable safety in adjuvant and metastatic colorectal cancer. Oxaliplatin-based therapy is becoming…”
Get full text

Patterns of mortality in domesticated ruminants in Ethiopia by Innocent, Giles T, Vance, Ciara, Ewing, David A, McKendrick, Iain J, Hailemariam, Solomon, Nwankpa, Veronica R, Allan, Fiona K, Schnier, Christian, Peters, Andrew R

“…Premature death of livestock is a problem in all ruminant production systems. While the number of premature ruminant deaths in a country is a reasonable…”
Get full text

Rectal Carriage of Enterohemorrhagic Escherichia coli O157 in Slaughtered Cattle by Low, J. Christopher, McKendrick, Iain J, McKechnie, Caroline, Fenlon, David, Naylor, Stuart W, Currie, Carol, Smith, David G. E, Allison, Lesley, Gally, David L

“…Escherichia coli O157:H7 is an important cause of diarrhea, hemorrhagic colitis, and potentially fatal human illness. Cattle are considered a primary reservoir…”
Get full text

Risk Factors for the Presence of High-Level Shedders of Escherichia coli O157 on Scottish Farms by Chase-Topping, Margo E, McKendrick, Iain J, Pearce, Michael C, MacDonald, Peter, Matthews, Louise, Halliday, Jo, Allison, Lesley, Fenlon, Dave, Low, J. Christopher, Gunn, George, Woolhouse, Mark E.J

“…Escherichia coli O157 infections are the cause of sporadic or epidemic cases of often bloody diarrhea that can progress to hemolytic uremic syndrome (HUS), a…”
Get full text

Immune checkpoint inhibitors as adjuvants: future challenges for pricing and reimbursement by Wieffer, H.M, McKendrick, J, Petropoulos, A, Saltman, D

Get full text

First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin by Cassidy, J., Twelves, C., Van Cutsem, E., Hoff, P., Bajetta, E., Boyer, M., Bugat, R., Burger, U., Garin, A., Graeven, U., McKendrick, J., Maroun, J., Marshall, J., Osterwalder, B., Pérez-Manga, G., Rosso, R., Rougier, P., Schilsky, R. L.

“…Purpose To evaluate the safety profile of capecitabine using data from a large, well-characterized population of patients with metastatic colorectal cancer…”
Get full text

3218 PACEBOM in relapsed/refractory (R/R) lymphoma in the rituximab (R) era by Tamjid, B, McKendrick, J, Doig, R, Hosking, P, James, P, Anthony, S, Hawkes, E

Get full text

Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study by VAN CUTSEM, Eric, TWELVES, Chris, MCKENDRICK, Joe, OSTERWALDER, Bruno, PEREZ-MANGA, Gumersindo, ROSSO, Riccardo, ROUGIER, Philippe, SCHMIEGEL, Wolff H, SEITZ, Jean-Francois, THOMPSON, Paul, VIEITEZ, Jose Maria, HARPER, Peter, CASSIDY, Jim, WEITZEL, Christof, ALLMAN, David, BAJETTA, Emilio, BOYER, Michael, BUGAT, Roland, FINDLAY, Mike, FRINGS, Stefan, JAHN, Michaela

“…To compare the efficacy and safety of orally administered capecitabine (Xeloda; Roche Laboratories, Inc, Nutley, NJ), a novel fluoropyrimidine carbamate…”
Get full text